Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

No longer available 1Completed 1

Sponsor Class

OTHER 6INDUSTRY 2

Study Type

Interventional 1Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Fibrosis 2Carcinoma, Hepatocellular 2Liver Cirrhosis 1Hepatitis D 1Hepatitis B, Chronic 1Hepatitis B 1Esophageal and Gastric Varices 1

Interventions

Gemcitabine 302Fluorouracil 296Oxaliplatin 269Bevacizumab 267Capecitabine 233Leucovorin 229pembrolizumab 215Irinotecan 185Cisplatin 142Cetuximab 142Nivolumab 131Paclitaxel 117130-nm albumin-bound paclitaxel 117Sorafenib 86Albumin-Bound Paclitaxel 75Docetaxel 65regorafenib 64atezolizumab 64IFL protocol 61Folfox protocol 61Trastuzumab 55Panitumumab 47durvalumab 46Ramucirumab 43Injections 43Sunitinib 41Drug Therapy 41Carboplatin 40trifluridine tipiracil drug combination 38lenvatinib 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Tenofovir × Gastrointestinal × Clear all
NCT05683548 2025-02-17

RCAP

Replicor Inc.

No longer available
Gastrointestinal

Hepatitis D, Esophageal and Gastric Varices, Fibrosis, Hepatitis B, Carcinoma, Hepatocellular, Liver Cirrhosis

NCT02224456 2022-02-14

Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis

GlaxoSmithKline

Phase 4 Completed
197 enrolled 27 charts
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hepatitis B, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡